Evidence for possible biological advantages of the newly emerging HIV-1 circulating recombinant form from malaysia - CRF33_01B in comparison to its progenitors - CRF01_AE and subtype B

Current HIV Research

Volumn 8, Issue 3, 2010, Pages 259-271

  Lau, Katherine A ^a   Wang, Bin ^a   Miranda Saksena, Monica ^a   Boadle, Ross ^b   Kamarulzaman, Adeeba ^c   Ng, Kee Peng ^c   Saksena, Nitin K ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Biological fitness; HIV 1 CRF01_AE; HIV 1 CRF33_01B; HIV 1 subtype B; Inter subtype recombinant; Malaysia

Indexed keywords

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; COMPARATIVE STUDY; CONTROLLED STUDY; GENOME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MALAYSIA; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; REVERSE TRANSCRIPTION; STEM CELL; SYNCYTIUM; VIRUS CELL INTERACTION; VIRUS INDUCTION; VIRUS INFECTIVITY; VIRUS RECOMBINANT; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS SURVIVAL; CELL CULTURE; CLASSIFICATION; GENETIC RECOMBINATION; GENETICS; GENOTYPE; GIANT CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MONONUCLEAR CELL; PATHOGENICITY; VIROLOGY;

APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; GENOTYPE; GIANT CELLS; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MALAYSIA; RECOMBINATION, GENETIC; VIRUS REPLICATION;

EID: 77954079840     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016210791111151     Document Type: Article

References (45)

1. Lau KA, Wang B, Saksena NK. Emerging trends of HIV epidemiology in Asia. AIDS Rev 2007; 9(4): 218-29.
2. Ou CY, Takebe Y, Weniger BG, et al. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet 1993; 341(8854): 1171-4.
3. Kalish ML, Luo CC, Weniger BG, et al. Early HIV type 1 strains in Thailand were not responsible for the current epidemic. AIDS Res Hum Retroviruses 1994; 10(11): 1573-5.
4. Weniger BG, Takebe Y, Ou CY, Yamazaki S. The molecular epidemiology of HIV in Asia. AIDS 1994; 8(Suppl 2): S13-28.
5. Ramos A, Nguyen L, Hu DJ, et al. New HIV type 1 CRF01_AE/B recombinants displaying unique distribution of breakpoints from incident infections among injecting drug users in Thailand. AIDS Res Hum Retroviruses 2003; 19(8): 667-74.
6. Tovanabutra S, Watanaveeradej V, Viputtikul K, et al. A New Circulating Recombinant Form, CRF15_01B, Reinforces the Linkage between IDU and Heterosexual Epidemics in Thailand. AIDS Research and Human Retroviruses 2003; 19(7): 561-7.
7. Tee KK, Pon CK, Kamarulzaman A, Ng KP. Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia. AIDS 2005; 19(2): 119-26.
8. Artenstein AW, VanCott TC, Mascola JR, et al. Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans. J Infect Dis 1995; 171(4): 805-10.
9. Robertson DL, Sharp PM, McCutchan FE, Hahn BH. Recombination in HIV-1. Nature 1995; 374(6518): 124-6.
10. Tee KK, Li XJ, Nohtomi K, Ng KP, Kamarulzaman A, Takebe Y. Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia. J Acquir Immune Defic Syndr 2006; 43(5): 523-9.
11. Wang B, Lau KA, Ong LY, et al. Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: evidence for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants. Virology 2007; 367(2): 288-97.
12. Lau KA, Wang B, Kamarulzaman A, Peng Ng K, Saksena NK. Near Full-Length Sequence Analysis of a Unique CRF01_AE/B Recombinant from Kuala Lumpur, Malaysia. AIDS Res Hum Retroviruses 2007; 23(9): 1139-45.
13. Lau KA, Wang B, Kamarulzaman A, Ngb KP, Saksena NK. Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res 2008; 6(2): 108-16.
14. Blackard JT, Renjifo BR, Mwakagile D, Montano MA, Fawzi WW, Essex M. Transmission of human immunodeficiency type 1 viruses with intersubtype recombinant long terminal repeat sequences. Virology 1999; 254(2): 220-5.
15. Rodriguez MA, Ding M, Ratner D, et al. High replication fitness and transmission efficiency of HIV-1 subtype C from India: Implications for subtype C predominance. Virology 2009; 385(2): 416-24.
16. Tovanabutra S, Beyrer C, Sakkhachornphop S, et al. The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002. AIDS Res Hum Retroviruses 2004; 20(5): 465-75.
17. Finney DJ. The Spearman-Karber method. In: Finney DJ, editor. Statistical Methods in Biological Assay. 2nd ed. London: Charles Griffin 1964; pp. 524-30.
18. Rodrigo AG, Goracke PC, Rowhanian K, Mullins JI. Quantitation of target molecules from polymerase chain reaction-based limiting dilution assays. AIDS Res Hum Retroviruses 1997; 13(9): 737-42.
19. Steain MC, Wang B, Dwyer DE, Saksena NK. HIV-1 co-infection, superinfection and recombination. Sex Health 2004; 1(4): 239-50.
20. Wang B, Lal RB, Dwyer DE, et al. Molecular and biological interactions between two HIV-1 strains from a coinfected patient reveal the first evidence in favor of viral synergism. Virology 2000; 274(1): 105-19.
21. Xiridou M, van Griensven F, Tappero JW, et al. The spread of HIV-1 subtypes B and CRF01_AE among injecting drug users in Bangkok, Thailand. J Acquir Immune Defic Syndr 2007; 45(4): 468-75.
22. Motomura K, Kusagawa S, Lwin HH, et al. Different subtype distributions in two cities in Myanmar: evidence for independent clusters of HIV-1 transmission. Aids 2003; 17(4): 633-6.
23. Nelson KE, Costello C, Suriyanon V, Sennun S, Duerr A. Survival of blood donors and their spouses with HIV-1 subtype E (CRF01 A_E) infection in northern Thailand, 1992-2007. AIDS 2007; 21(Suppl 6): S47-54.
24. Chuenchitra T, Wasi C, Louisirirojchanakul S, et al. Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression. AIDS Res Hum Retroviruses 2003; 19(4): 293-305.
25. Tee KK, Kamarulzaman A, Ng KP. Short communication: low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia. AIDS Res Hum Retroviruses 2006; 22(2): 121-4.
26. Fleury HJ, Toni T, Lan NT, et al. Susceptibility to antiretroviral drugs of CRF01_AE, CRF02_AG, and subtype C viruses from untreated patients of Africa and Asia: comparative genotypic and phenotypic data. AIDS Res Hum Retroviruses 2006; 22(4): 357-66.
27. Sukasem C, Churdboonchart V, Sirisidthi K, et al. Genotypic resistance mutations in treatment-naive and treatment-experienced patients under widespread use of antiretroviral drugs in Thailand: implications for further epidemiologic surveillance. Jpn J Infect Dis 2007; 60(5): 284-9.
28. Peeters M, Liegeois F, Torimiro N, et al. Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. J Virol 1999; 73(9): 7368-75.
29. Njai HF, Gali Y, Vanham G, et al. The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness. Retrovirology 2006; 3(1): 40.
30. Zhong P, Peeters M, Janssens W, et al. Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D. AIDS Res Hum Retroviruses 1995; 11(2): 239-48.
31. Utaipat U, Duerr A, Rudolph DL, et al. Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives. AIDS Res Hum Retroviruses 2002; 18(1): 1-11.
32. Mastro TD, de Vincenzi I. Probabilities of sexual HIV-1 transmission. AIDS 1996; 10(Suppl A): S75-82.
33. HIV/AIDS EGotJUNPo. Implications of HIV variability for transmission: scientific and policy issues. Expert Group of the Joint United Nations Programme on HIV/AIDS. AIDS 1997; 11(4): UNAIDS1-15.
34. Ball SC, Abraha A, Collins KR, et al. Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. J Virol 2003; 77(2): 1021-38.
35. Arien KK, Abraha A, Quinones-Mateu ME, Kestens L, Vanham G, Arts EJ. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J Virol 2005; 79(14): 8979-90.
36. Rangel HR, Weber J, Chakraborty B, et al. Role of the human immunodeficiency virus type 1 envelope gene in viral fitness. J Virol 2003; 77(16): 9069-73.
37. Troyer RM, Collins KR, Abraha A, et al. Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression. J Virol 2005; 79(14): 9006-18.
38. Quinones-Mateu ME, Ball SC, Marozsan AJ, et al. A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression. J Virol 2000; 74(19): 9222-33.
39. Arts EJ, Quinones-Mateu ME. Sorting out the complexities of HIV-1 fitness. AIDS 2003; 17(5): 780-1.
40. Sylwester A, Murphy S, Shutt D, Soll DR. HIV-induced T cell syncytia are self-perpetuating and the primary cause of T cell death in culture. J Immunol 1997; 158(8): 3996-4007.
41. Sylwester A, Daniels K, Soll DR. The invasive and destructive behavior of HIV-induced T cell syncytia on collagen and endothelium. J Leukoc Biol 1998; 63(2): 233-44.
42. Frankel SS, Wenig BM, Burke AP, et al. Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 1996; 272(5258): 115-7.
43. Lewin-Smith M, Wahl SM, Orenstein JM. Human immunodeficiency virus-rich multinucleated giant cells in the colon: a case report with transmission electron microscopy, immunohistochemistry, and in situ hybridization. Mod Pathol 1999; 12(1): 75-81.
44. Burke DS. Recombination in HIV: an important viral evolutionary strategy. Emerg Infect Dis 1997; 3(3): 253-9.
45. Steain MC, Wang B, Saksena NK. The possible contribution of HIV-1-induced syncytia to the generation of intersubtype recombinants in vitro. AIDS 2008; 22(9): 1009-17